Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover which credit cards provide the best points redemption options. Make informed choices to maximize your rewards potential.
25,708 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Cleo Capital urges investors to recalibrate Nvidia's growth outlook as AI infrastructure spending moves from explosiv...
Georgia lawmakers have postponed plans to remove barcode voting from ballots, keeping QR-code systems in use and dela...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
A 73-year-old worker with an $800,000 401(K) cannot roll it into a new IRA after leaving a former employer, revealing...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
Micron just beat earnings, but the stock didn’t soar. This article breaks down what happened, how AI demand, margins,...
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...